---
title: "COVID neutrophiles study"
subtitle: "or the pains of patient-based data"
cache: true
fig-align: center
width: 1280
height: 720
margin: 0.05
self-contained: false
format:
  revealjs:
    theme: white
    footer: Pains of patient-based data
    logo: images/dag_logo.jpg
---

```{r setup, include=FALSE}
library(tidyverse)
library(targets)
library(gt)
library(ape)
library(UpSetR)
```


## People

::: {.absolute top="15%" left="25%" width="20%"}
![James Chalmers](images/james-chalmers.jpg){style="border-radius: 5%; border: 8px solid #e3f4fc; text-align: center"}
:::

::: {.absolute top="15%" right="25%" width="20%"}
![Merete Long](images/merete-long_0.jpg){style="border-radius: 5%; border: 8px solid #e3f4fc; text-align: center"}
:::

::: {.absolute bottom="15%" left="26%"}
[Molecular and Clinical Medicine, School of Medicine]{style="font-size: 0.7em;"}
:::

## Neutrophils

::: {layout="[[50, 50]]"}
![](images/neutrophil.png)

-   type of white blood cell
-   part of innate immune system
-   first line of defence against pathogens
-   abundant, 10^11^ are produced daily 
:::

## Motivation

-   COVID casues acute respiratory distress syndrome (ARDS)
-   Mortality in ADSR correlates with neutrophil count
-   Neutrophil elastase is believed to cause neutrophil-induced lung damage
-   It is activated by dipeptidyl peptidase 1 (cathepsin C)
-   Brensocatib is a orally delivered DPP1 inhibitor
-   The drug might help with COVID recovery

::: notes
Neutrophil elastase is a protease secreted by neutrophils during inflammation, destroys bacteria and host tissue.
:::

## Study

-   Brensocatib vs placebo trial of hospital COVID patients
-   145 participants enrolled
-   Neutrophils from blood samples were isolated

. . .

Let's do proteomics!


## The file {.smaller}

Spectronaut output, `r targets::tar_read(spectronaut_nrow) |> prettyNum(big.mark = ",")` rows

::: {style="font-size: 0.9em"}
```{r}
options(width = 150)
tar_read(spectronaut_head) |> 
  print(n = 100)
```
:::

## Design

-   5 time points
-   5 batches
-   Gaps in data
-   Participants don't return for sampling on day 29
-   Participants die

## Gaps in data

```{r}
#| fig-align: center
#| fig-width: 12
#| fig-height: 7
tar_read(fig_participant_1_29) 
```

## Batch effects!

::: {.absolute top="15%" left="25%" width="60%"}
```{r}
#| fig-width: 6
tar_read(fig_counts_batch)
```
:::

## Participants

::: {style="height: 80%; width: fit-content; overflow-y: scroll; margin-left: auto; margin-right: auto;"}
```{r}
tar_read(participants) |> 
  mutate(No = row_number(), .before = 1) |> 
  gt() |> 
  tab_style(
    style = cell_text(font = "monospace"),
    locations = cells_body(columns = on_drug)
  )
```
:::

## Participants

::: {.absolute top="25%" left="10%" width="80%"}
```{r}
#| fig-width: 11
#| fig-height: 3.5
tar_read(fig_participat_stats) 
```
:::

## Protein detection

::: {.absolute top="15%" left="10%" width="90%"}
```{r}
tar_read(fig_detection)
```
:::

## Clustering

```{r}
#| fig-height: 9
#| fig-align: center
tar_read(fig_clustering_circular) 
```

## PCA and UMAP

::: {layout="[[-0.2], [1, 1]]"}
```{r}
#| fig-width: 7
tar_read(fig_pca)
```

```{r}
#| fig-width: 7
tar_read(fig_umap)
```
:::

## Target protein {.smaller}

Brensocatib is an orally delivered selective, competitive, and reversible inhibitor of DPP1.

. . .

::: {.absolute top="20%" left="30%" width="60%"}
```{r}
#| fig-width: 5
tar_read(fig_dpp1)
```
:::

## Differential abundance {.smaller}

##### Full model

`~ treatment + day + batch + age_group + sex`

##### Baseline

-   treatment = placebo
-   day = 1
-   batch = 3
-   age_group = \<50
-   sex = M

## Differential abundance full

```{r}
#| fig-width: 8
#| fig-asp: 0.9
#| fig-align: center
tar_read(fig_ma_full) 
```

## Batch effect examples

::: {.absolute top="17%" left="10%" width="90%"}
```{r}
tar_read(fig_batch_examples)
```
:::

## Gene set enrichment for batch effect

::: {layout="[[-1],[1],[-1]]"}
```{r}
tar_load(gse_batch5)
map_dfr(names(gse_batch5), function(ont) {
  gse_batch5[[ont]] |> 
    filter(padj < 0.01) |> 
    add_column(ontology = ont, .before = 1) |> 
    mutate(across(c(pval, padj, NES), ~signif(.x, 3))) |> 
    select(ontology, term, term_name, padj, NES, size, contrast) |> 
    mutate(ontology = recode(ontology, go = "GO", re = "Reactome", kg = "KEGG"))
}) |> 
  gt()
```
:::

## Day 29 {.smaller}

Batch 4 and 5 only

`~ treatment + age_group + sex`

::: {layout="[[1.4, 1]]"}
```{r}
#| fig-width: 7
tar_read(fig_ma_day29_b4) + ggtitle("Batch 4")
```

```{r}
#| fig-width: 5
tar_read(fig_ma_day29_b5) + ggtitle("Batch 5")
```
:::

## Day 29 overlap

::: {layout="[[-1], [-1, 4, -1], [-1]]"}
```{r}
#| fig-width: 6
#| fig-height: 4
upset(fromList(tar_read(ups_day29))) 
```
:::

## Day 29 best guess {.smaller}

```{r}
tar_read(dal_day29_treatment_best) |> 
  select(-protein_names) |> 
  gt()
```

```{r}
#| fig-align: center
#| fig-height: 4
tar_read(fig_day29_best)
```

::: notes
Cathepsin C (the target) is a cysteine protease, while cathepsin G is a serine protease.

Azurocidin is an antimicrobial protein residing in lysosome of a neutrophil.
:::

## Per participant DA

```{r}
tar_read(fig_participant_1_29)
```

-   Find log-ratio of intensities at 29 and 1 days
-   Differential abundance

## log-ratio day 29 to day1

::: {layout="[[-1], [-1, 5, -1], [-1]]"}
```{r}
tar_read(fig_volcano_dl)
```
:::

```{r}
tar_load(gse_dl)
tb <- map_dfr(names(gse_dl), function(ont) {
  gse_dl[[ont]] |> 
    filter(padj < 0.01) |> 
    add_column(ontology = ont, .before = 1) |> 
    mutate(
      padj = signif(padj, 2),
      NES = signif(NES, 3)
    ) |> 
    select(ontology, term, term_name, padj, NES, size, contrast) |> 
    mutate(ontology = recode(ontology, go = "GO", re = "Reactome", kg = "KEGG"))
})
```

## Gene-set enrichment drug {.scrollable .smaller}

:::: {.panel-tabset}

### Drug

```{r}
tb |>
  filter(contrast == "drug") |>
  select(-contrast) |> 
  gt() |> 
  fmt_scientific(padj, decimals = 1)
```

### Placebo

```{r}
tb |>
  filter(contrast == "placebo") |>
  select(-contrast) |> 
  gt() |> 
  fmt_scientific(padj, decimals = 1)
```

:::

## Drug vs placebo

```{r}
#| fig-width: 5
#| fig-align: center
tar_read(fig_volcano_dl_drug_vs_placebo)
```

## Drug vs placebo

```{r, fig.width=10, fig.height=8}
#| fig-align: center
tar_read(fig_dl_drug_vs_placebo) 
```

## Conclusions? {auto-animate=true}

::: {.fragment .fade-in}
This is not the end of the story
:::

::: {.fragment .fade-in}
Humans are more different than mice
:::

::: {.fragment .fade-in}
Strong batch effects
:::

::: {.fragment .fade-in}
Lots of replicates - meh
:::

::: {.fragment .fade-in}
Messy!
:::


## Conclusions? {auto-animate=true}

::: {style="margin-top: 100; margin-left: auto; margin-right: auto; font-size: 4em; color: red;"}
Messy!
:::

## This is what we do

::::: {layout="[[-22, 54, -22], [100]]"}

![](images/needle.png)


:::: {.fragment}
::: {style="font-size: 0.5em"}
Italian artist Sven Sachsalber, at *Palais de Tokyo* in Paris, searching for a needle in a haystack, hidden there by the museum's director (November 2014).
:::
::::

:::: {.fragment}
::: {style="font-size: 0.5em"}
He found the needle after 18 hours.
:::
::::


:::::

